Skip to content
On this page:OverviewPublicationsResearchersInstitutionsOpen access
PICO Portalanswers from OpenAlex

Addgene

InstitutionResearch output, impact & collaborations

Addgene is a institution indexed in PICO Portal from OpenAlex.

What is known about Addgene?

PICO Portalrecord summary

Addgene is a research organisation in Cambridge, US. OpenAlex records 483 works and 56,342 citations for it. 356 researchers list it as their most recent affiliation.

How many works does Addgene have?

PICO Portalindexed works

Addgene has 483 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Addgene have?

PICO Portalcitation count

Addgene has 56,342 citations in the OpenAlex counts PICO Portal stores.

How many researchers are at Addgene?

PICO Portalresearcher count

Addgene has 356 researchers in the PICO Portal index.

What is the average h-index at Addgene?

PICO Portalavg h-index

Addgene has an average h-index of 74 in OpenAlex.

What is the ROR of Addgene?

PICO Portalror

The ROR for Addgene is on the source record.

What is the OpenAlex record for Addgene?

PICO Portalopenalex

The OpenAlex for Addgene is on the source record.

Who are the most-cited researchers behind Addgene?

PICO Portaltop researchers by citations
1
Jochen K. Lennerz · Lung Cancer Treatments and Mutations
629 works22,916 citations

What are the most-cited papers on Addgene?

PICO Portalmost cited works
A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells
Ken Cadwell, John Y. Liu, Sarah L. Brown, Hiroyuki Miyoshi, Joy Loh, Jochen K. Lennerz, Chieko Kishi, Wumesh KC, Javier A. Carrero, Steven R. Hunt, Christian D. Stone, Elizabeth M. Brunt, Ramnik J. Xavier, Barry P. Sleckman, Ellen Li, Noboru Mizushima, Thaddeus S. Stappenbeck, Herbert W. Virgin
Nature. 20081,507 CitationsOPEN ACCESS
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
Marina Cella, Anja Fuchs, William Vermi, Fabio Facchetti, Karel Otero, Jochen K. Lennerz, Jason M. Doherty, Jason C. Mills, Marco Colonna
Nature. 20081,223 CitationsOPEN ACCESS
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in <i>ALK</i> -Rearranged Lung Cancer
Justin F. Gainor, Leila Dardaei, Satoshi Yoda, Luc Friboulet, Ignaty Leshchiner, Ryohei Katayama, Ibiayi Dagogo‐Jack, Shirish M. Gadgeel, Katherine R. Schultz, Manrose Singh, Emily Chin, Melissa Parks, Dana Lee, Richard H. DiCecca, Elizabeth L. Lockerman, Tiffany G. Huynh, Jennifer Logan, Lauren L. Ritterhouse, Long P. Le, Ashok Muniappan, Subba R. Digumarthy, Colleen L. Channick, Colleen Keyes, Gad Getz, Dora Dias‐Santagata, Rebecca S. Heist, Jochen K. Lennerz, Lecia V. Sequist, Cyril H. Benes, A. John Iafrate, Mari Mino–Kenudson, Jeffrey A. Engelman, Alice T. Shaw
Cancer Discovery. 20161,157 CitationsOPEN ACCESS
COVID-19-neutralizing antibodies predict disease severity and survival
Wilfredo F. García-Beltrán, Evan C. Lam, Michael G. Astudillo, Diane Yang, Tyler E. Miller, Jared Feldman, Blake M. Hauser, Timothy M. Caradonna, Kiera Clayton, Adam D. Nitido, Mandakolathur R. Murali, Galit Alter, Richelle C. Charles, Anand S. Dighe, John A. Branda, Jochen K. Lennerz, Daniel Lingwood, Aaron G. Schmidt, A. John Iafrate, Alejandro B. Balazs
Cell. 2020793 CitationsOPEN ACCESS
Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma
Lipika Goyal, Supriya K. Saha, Leah Y. Liu, Giulia Siravegna, Ignaty Leshchiner, Leanne G. Ahronian, Jochen K. Lennerz, Phuong Vu, Vikram Deshpande, Avinash Kambadakone, Benedetta Mussolin, Stephanie Reyes, Laura E. Henderson, Jiaoyuan Elisabeth Sun, Emily E. Van Seventer, Joseph M. Gurski, Sabrina Baltschukat, Barbara Schacher-Engstler, Louise Barys, Christelle Stamm, Pascal Furet, David P. Ryan, James R. Stone, A. John Iafrate, Gad Getz, Diana Graus Porta, Ralph Tiedt, Alberto Bardelli, Dejan Juric, Ryan B. Corcoran, Nabeel Bardeesy, Andrew X. Zhu
Cancer Discovery. 2016550 CitationsOPEN ACCESS

How much of the research on Addgene is open access?

PICO Portalopen access share
83%OPEN ACCESS
Gold
0%
Green
50%
Hybrid
8%
Bronze
25%
Closed
17%

Related on PICO Portal

470M+ articles · 14-day free trial